Agios Pharm
Price & Volume
Stats
See moreOpen | $39.96 |
Previous Close | $40.55 |
Day Range | $39.52-$40.55 |
52W Range | $22.24-$46 |
Market Cap | $2.4B |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $66M |
Revenue Growth (YoY) | 137.7% |
Gross Profit (12 Mos) | -$288.4M |
Diluted EPS | -$7.26 |
News
See moreYahoo Finance • 4 days ago
Here's Why Shares in Novo Nordisk Rival, Agios Pharmaceutical, Soared This Week
Yahoo Finance • 7 days ago
FDA Accepts Agios' SNDA For Mitapivat In Sickle Cell Disease With Nov '26 PDUFA Date; Stock Up
Yahoo Finance • last month
Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease
Yahoo Finance • last month
Agios Enters Global License Agreement For Cevidoplenib
About
CEO | Mr. Brian M. Goff M.B.A. |
Address | 88 Sidney Street, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 539 |